Impact of the COVID-19 Pandemic on Pediatric Cystic Fibrosis Pulmonary Exacerbations

If you need an accessible version of this item, please email your request to digschol@iu.edu so that they may create one and provide it to you.
Date
2020
Language
English
Embargo Lift Date
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Abstract

To assess the impact of COVID-19 restrictions on cystic fibrosis (CF) pulmonary exacerbations (PEx) we performed a retrospective review of PEx events at our CF Center and compared the rate of PEx in 2019 vs 2020. Restrictions on social interaction due to the COVID-19 pandemic were associated with a lower rate of PEx at our pediatric CF Center, suggesting that these restrictions also reduced exposure to other respiratory viral infection in children with CF.

Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Patel, S., Thompson, M., Slaven, J., Sanders, D., & Ren, C. (2020). Impact of the COVID-19 Pandemic on Pediatric Cystic Fibrosis Pulmonary Exacerbations. Authorea Preprints. https://doi.org/10.22541/au.160491826.69450223/v1
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Authorea Preprints
Source
Other
Alternative Title
Type
Preprint
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Version
Full Text Available at
This item is under embargo {{howLong}}